TMA’s innovative, nutrition-focused research proposal is one of 15 projects selected in crowd-sourced search for ideas ...
Patients with dermatomyositis in the US experience substantial variability in treatment, high glucocorticoid exposure, and significant healthcare utilization.
The results of the Phase 3 VALOR trial were published in the New England Journal of Medicine, underscoring the practice-changing potential of ...
Broyden has to be diligent and deliberate with her skin protection, noting that she applies sunscreen in “every single spot ...
Polymyositis (PM) and dermatomyositis (DM) may involve the striated muscle of the esophagus, leading to abnormal swallowing that in turn can lead to malnutrition and/or aspiration. Esophageal disease ...
argenx remains a dominant player in the anti-FcRn market, with Vyvgart approved for gMG, CIDP, and ITP in Japan. The ALKIVIA trial aims to expand Vyvgart's use in myositis, a rare autoimmune disease ...
On May 1-2, the Huntsville community will gather at the U.S. Space & Rocket Center for the Myositis Moon Walk. Organizers say ...
An investigational monoclonal antibody targeting interferon beta (IFNβ) led to rapid and pronounced reductions in disease activity in adults with dermatomyositis, a randomized phase II study showed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results